Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › FGF21-FC fusion proteins for treating metabolic disorders

FGF21-FC fusion proteins for treating metabolic disorders

US Patent 10076554 · Granted Sep 18, 2018

Estimated economic value: $14,756,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fibroblast growth factor-21-Fc fusion proteins2024
Fibroblast growth factor-21-Fc fusion proteins2024
Fibroblast growth factor-21-Fc fusion proteins2024
Fibroblast growth factor-21-Fc fusion proteins2024
Fibroblast growth factor-21-Fc fusion proteins2024
Fibroblast growth factor-21-Fc fusion proteins2024
Methods of treating FGF21-associated disorders2023
Methods of treating FGF21-associated disorders2023
Chemically modified messenger RNA's2022
Antibodies against growth differentiation factor 15 and uses thereof2022
Methods of treating FGF21-associated disorders2022
Methods of treating FGF21-associated disorders2022